SREBF1 and metabolic syndrome: In animal models of NAFLD and metabolic syndrome, Cr supplementation downregulated the expression of sterol regulatory element-binding protein-1 (SREBP-1) mRNA, which is a key transcription factors involved in the synthesis of cholesterol and fatty acids (28, 33, 37).